Skip to content
by Legal Desire
26 April 2024

Latham Advises Canaan and Brandon Capital on Pathios’ US$25 Million Series B

Advising firms

Deal team

2 lawyers named
LawyerFirmSeniorityPracticeOffice
Shing Lo Lead Latham & Watkins LLP Partner corporate London
Toni Adejuyigbe Latham & Watkins LLP Associate Not stated Not stated

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 25m (US$25 million)
What the figure measures
Issue size
Client
Not stated
Counterparties
Canaan (Investor)
Brandon Capital (Investor)
Bristol Myers Squibb (Investor)
Pathios Therapeutics Limited (Issuer)